Elanco Announces Agreement to Acquire ChemGen Corp.

US - Elanco, the animal health division of Eli Lilly and Company, yesterday announced that Lilly has signed an agreement to acquire ChemGen, Corp., a privately held bioscience company specializing in the development and commercialization of innovative feed enzyme products that improve the efficiency of poultry, egg, and meat production.
calendar icon 25 January 2012
clock icon 2 minute read
© 2000 - 2024 - Global Ag Media. All Rights Reserved | No part of this site may be reproduced without permission.